The FDA approved RSV vaccine Abrysvo, which protects against lung infections, for high-risk adults as young as 18 with ...

Since an exacerbation and worsening of her COPD symptoms in summer, columnist Caroline Gainer now uses a stationary ...

There is no need to do any special preparation for this test. However, if you are on oxygen therapy, oxygen values must be constant for 20 minutes before the test. If you are taking medication to make ...

Common symptoms of chronic obstructive pulmonary disease, or COPD, include shortness of breath, a frequent cough or cough that produces a lot of mucus, wheezing, and tightness in the chest. Excess ...

Budesonide for inhalation (brand name, Pulmicort; AstraZeneca) is a corticosteroid used to prevent breathing difficulties, chest tightness, wheezing, and coughing caused by respiratory disorders, such ...

Abediterol is a novel, once-daily, fine-particle therapy being developed by AstraZeneca for the treatment of chronic obstructive pulmonary disease (COPD). The investigational drug is a long-acting ...

Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder that causes several symptoms which make breathing difficult. These include persistent cough with mucus, wheezing, and shortness ...

Caroline Gainer is from West Virginia, the state with the highest rate of COPD in the United States. She was diagnosed with moderate-to-severe COPD in 2013 after a pneumothorax (lung collapse). After ...

Trelegy Ellipta is a once-daily, single inhaler triple therapy from GSK, in collaboration with Innoviva, approved as a long-term maintenance treatment for certain patients with chronic obstructive ...

Many of us with chronic obstructive pulmonary disease (COPD) have received medical devices to help with our breathing. At first, it seemed to me that some of these devices worked better than others.

The U.S. Food and Drug Administration (FDA) has approved Abrysvo, a vaccine that protects against lung infections caused by the respiratory syncytial virus — commonly known as RSV — for adults as ...

COPD is among the leading causes of death in industrialized countries, and new pharmacological treatments are being developed to help patients with this disease. But a spectrum of non-pharmacological ...